NBIX Neurocrine Biosciences | $145.51 +0.9% | 10/6/2026 | | Initiated Coverage | $207.00 | Buy | 00.00% | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 10/6/2026 |
XENE Xenon Pharmaceuticals | $36.57 -2.7% | 10/6/2026 | | Initiated Coverage | $73.00 | Buy | 00.00% | View details for Guggenheim rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 10/6/2026 |
YUM Yum! Brands | $139.89 +2.1% | 10/6/2026 | | Lower Price Target | $180.00 ➝ $155.00 | Buy | 00.00% | View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 10/6/2026 |
RAPP Rapport Therapeutics | $31.15 -3.2% | 10/5/2026 | | Initiated Coverage | $65.00 | Buy | 00.00% | View details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026 |
MPLT Maplight Therapeutics | $9.69 +4.5% | 10/5/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Maplight Therapeutics (NASDAQ:MPLT) on 10/5/2026 |
LBRX LB Pharmaceuticals | $34.26 -1.0% | 10/5/2026 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/5/2026 |
RAPP Rapport Therapeutics | $31.15 -3.2% | 10/5/2026 | | Set Price Target | $65.00 | Buy | 00.00% | View details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026 |
GMAB Genmab A/S | $37.80 -1.8% | 10/5/2026 | | Boost Price Target | $45.00 ➝ $54.00 | Buy | 00.00% | View details for Guggenheim rating of Genmab A/S (NASDAQ:GMAB) on 10/5/2026 |
PCVX Vaxcyte | $66.70 -9.6% | 10/5/2026 | | Boost Price Target | $116.00 ➝ $125.00 | Buy | 00.00% | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 10/5/2026 |
MCD McDonald's | $232.69 -0.2% | 10/5/2026 | | Lower Price Target | $290.00 ➝ $250.00 | Neutral | 00.00% | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/5/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
OVID Ovid Therapeutics | $2.37 +1.3% | 10/5/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Guggenheim rating of Ovid Therapeutics (NASDAQ:OVID) on 10/5/2026 |
YSWY Yesway | $20.25 +0.9% | 10/5/2026 | | Reiterated Rating | $32.00 | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 10/5/2026 |
FHTX Foghorn Therapeutics | $1.97 -1.5% | 10/2/2026 | | Lower Price Target | $12.00 ➝ $5.00 | Buy | 00.00% | View details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026 |
SGMT Sagimet Biosciences | $8.76 -3.0% | 10/2/2026 | | Boost Price Target | $25.00 ➝ $26.00 | Buy | 00.00% | View details for Guggenheim rating of Sagimet Biosciences (NASDAQ:SGMT) on 10/2/2026 |
MBX MBX Biosciences | $56.92 -2.8% | 10/2/2026 | | Boost Price Target | $88.00 ➝ $150.00 | Buy | 00.00% | View details for Guggenheim rating of MBX Biosciences (NASDAQ:MBX) on 10/2/2026 |
NKE NIKE | $34.60 +1.9% | 10/2/2026 | | Reiterated Rating | $60.00 ➝ $50.00 | Buy | 00.00% | View details for Guggenheim rating of NIKE (NYSE:NKE) on 10/2/2026 |
FHTX Foghorn Therapeutics | $1.97 -1.5% | 10/2/2026 | | Lower Price Target | $12.00 ➝ $5.00 | Buy | 00.00% | View details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026 |
ACN Accenture | $193.67 -0.7% | 10/2/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Accenture (NYSE:ACN) on 10/2/2026 |
WAT Waters | $436.18 -0.9% | 10/1/2026 | | Boost Price Target | $440.00 ➝ $490.00 | Buy | 00.00% | View details for Guggenheim rating of Waters (NYSE:WAT) on 10/1/2026 |
TWST Twist Bioscience | $166.97 -18.6% | 10/1/2026 | | Boost Price Target | $107.00 ➝ $212.00 | Buy | 00.00% | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 10/1/2026 |
TEM Tempus AI | $71.98 -13.8% | 10/1/2026 | | Boost Price Target | $65.00 ➝ $92.00 | Buy | 00.00% | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 10/1/2026 |
NTRA Natera | $400.65 -5.9% | 10/1/2026 | | Boost Price Target | $360.00 ➝ $475.00 | Buy | 00.00% | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 10/1/2026 |
ILMN Illumina | $273.54 -6.9% | 10/1/2026 | | Boost Price Target | $226.00 ➝ $305.00 | Buy | 00.00% | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 10/1/2026 |
GH Guardant Health | $170.69 -8.8% | 10/1/2026 | | Boost Price Target | $190.00 ➝ $200.00 | Buy | 00.00% | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 10/1/2026 |
DHR Danaher | $215.49 -2.6% | 10/1/2026 | | Boost Price Target | $200.00 ➝ $250.00 | Buy | 00.00% | View details for Guggenheim rating of Danaher (NYSE:DHR) on 10/1/2026 |
CYRX CryoPort | $17.80 -1.9% | 10/1/2026 | | Boost Price Target | $16.00 ➝ $19.00 | Buy | 00.00% | View details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 10/1/2026 |
BRKR Bruker | $60.50 -5.3% | 10/1/2026 | | Boost Price Target | $70.00 ➝ $72.00 | Buy | 00.00% | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 10/1/2026 |
BLLN Billiontoone | $99.94 -8.4% | 10/1/2026 | | Boost Price Target | $125.00 ➝ $128.00 | Buy | 00.00% | View details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 10/1/2026 |
ADPT Adaptive Biotechnologies | $26.90 -9.9% | 10/1/2026 | | Boost Price Target | $25.00 ➝ $32.00 | Buy | 00.00% | View details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 10/1/2026 |
NFLX Netflix | $68.69 +1.8% | 10/1/2026 | | Reiterated Rating | $75.00 ➝ $80.00 | Buy | 00.00% | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/1/2026 |
GRAL GRAIL | $137.28 -10.9% | 10/1/2026 | | Boost Price Target | $75.00 ➝ $155.00 | Buy | 00.00% | View details for Guggenheim rating of GRAIL (NASDAQ:GRAL) on 10/1/2026 |
WGS GeneDx | $71.52 -6.2% | 10/1/2026 | | Boost Price Target | $74.00 ➝ $83.00 | Buy | 00.00% | View details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 10/1/2026 |
DKS DICK'S Sporting Goods | $134.64 -1.8% | 9/30/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 9/30/2026 |
NEOG Neogen | $11.96 -8.1% | 9/30/2026 | | Reiterated Rating | $12.00 ➝ $14.00 | Buy | 00.00% | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 9/30/2026 |
ZBIO Zenas BioPharma | $26.94 -3.2% | 9/30/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 9/30/2026 |
BWXT BWX Technologies | $145.83 +7.7% | 9/30/2026 | | Reiterated Rating | $192.00 | Buy | 00.00% | View details for Guggenheim rating of BWX Technologies (NYSE:BWXT) on 9/30/2026 |
MDB MongoDB | $360.71 +0.4% | 9/29/2026 | | Reiterated Rating | $560.00 | Buy | 00.00% | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 9/29/2026 |
AIR AAR | $103.98 +1.7% | 9/29/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of AAR (NYSE:AIR) on 9/29/2026 |
WMG Warner Music Group | $27.61 -0.1% | 9/29/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 9/29/2026 |
COST Costco Wholesale | $935.85 +1.3% | 9/28/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Costco Wholesale (NASDAQ:COST) on 9/28/2026 |
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening.
The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today |
DIS Walt Disney | $103.92 +0.3% | 9/28/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 9/28/2026 |
FSLR First Solar | $179.80 +2.1% | 9/28/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 9/28/2026 |
ABSI Absci | $10.27 -10.9% | 9/28/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 9/28/2026 |
KRSA Cyclerion Therapeutics | $31.77 +3.4% | 9/28/2026 | | Initiated Coverage | $70.00 | Buy | 00.00% | View details for Guggenheim rating of Cyclerion Therapeutics (NASDAQ:KRSA) on 9/28/2026 |
ZS Zscaler | $212.25 +5.2% | 9/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 9/25/2026 |
AKAM Akamai Technologies | $108.62 +0.6% | 9/25/2026 | | Boost Price Target | $190.00 ➝ $225.00 | Buy | 00.00% | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 9/25/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $19.55 -3.3% | 9/25/2026 | | Boost Price Target | $40.00 ➝ $60.00 | Buy | 00.00% | View details for Guggenheim rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 9/25/2026 |
DRI Darden Restaurants | $203.37 +1.8% | 9/25/2026 | | Reiterated Rating | $235.00 | Buy | 00.00% | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 9/25/2026 |
ENTX Entera Bio | $2.53 -3.4% | 9/24/2026 | | Initiated Coverage | $11.00 | Buy | 00.00% | View details for Guggenheim rating of Entera Bio (NASDAQ:ENTX) on 9/24/2026 |
OKTA Okta | $218.67 +0.2% | 9/24/2026 | | Boost Price Target | $188.00 ➝ $227.00 | Buy | 00.00% | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 9/24/2026 |
TVTX Travere Therapeutics | $55.98 -2.9% | 9/24/2026 | | Boost Price Target | $75.00 ➝ $89.00 | Buy | 00.00% | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/24/2026 |
ENTX Entera Bio | $2.53 -3.4% | 9/24/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Entera Bio (NASDAQ:ENTX) on 9/24/2026 |
P Everpure | $147.03 +2.2% | 9/24/2026 | | Reiterated Rating | $150.00 | Buy | 00.00% | View details for Guggenheim rating of Everpure (NYSE:P) on 9/24/2026 |
TLSI TriSalus Life Sciences | $4.27 -2.5% | 9/23/2026 | | Set Price Target | $12.00 | | 00.00% | View details for Guggenheim rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/23/2026 |
DPZ Domino's Pizza | $302.87 +1.9% | 9/23/2026 | | Lower Price Target | $440.00 ➝ $325.00 | Neutral | 00.00% | View details for Guggenheim rating of Domino’s Pizza (NASDAQ:DPZ) on 9/23/2026 |
AZO AutoZone | $2,900.90 +3.3% | 9/23/2026 | | Lower Price Target | $4,000.00 ➝ $3,750.00 | Buy | 00.00% | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 9/23/2026 |
CMPX Compass Therapeutics | $1.00 +3.9% | 9/23/2026 | | Lower Price Target | $4.00 | Buy | 00.00% | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 9/23/2026 |
EDIT Editas Medicine | $2.73 -2.2% | 9/23/2026 | | Upgrade | $5.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of Editas Medicine (NASDAQ:EDIT) on 9/23/2026 |
FOXA FOX | $62.08 -2.0% | 9/23/2026 | | Reiterated Rating | $85.00 | Buy | 00.00% | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 9/23/2026 |
BLSM BlossomHill Therapeutics | $17.29 -13.3% | 9/21/2026 | | Boost Price Target | $30.00 ➝ $40.00 | Buy | 00.00% | View details for Guggenheim rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/21/2026 |
LOW Lowe's Companies | $183.80 +2.4% | 9/21/2026 | | Reiterated Rating | $275.00 | Buy | 00.00% | View details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 9/21/2026 |
ADSK Autodesk | $231.28 +4.4% | 9/21/2026 | | Reiterated Rating | $283.00 | Buy | 00.00% | View details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 9/21/2026 |
LOW Lowe's Companies | $183.80 +2.4% | 9/21/2026 | | Reiterated Rating | $275.00 | Buy | 00.00% | View details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 9/21/2026 |
QSR Restaurant Brands International | $70.28 +0.6% | 9/18/2026 | | Boost Price Target | $85.00 ➝ $86.00 | Buy | 00.00% | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 9/18/2026 |
LLY Eli Lilly and Company | $1,157.61 +1.3% | 9/18/2026 | | Boost Price Target | $1,273.00 ➝ $1,284.00 | Buy | 00.00% | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 9/18/2026 |
TTD Trade Desk | $11.92 -0.5% | 9/18/2026 | | Reiterated Rating | $12.00 ➝ $13.00 | Neutral | 00.00% | View details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 9/18/2026 |
ACN Accenture | $193.67 -0.7% | 9/18/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Accenture (NYSE:ACN) on 9/18/2026 |
SIRI Sirius XM | $26.36 +0.2% | 9/17/2026 | | Reiterated Rating | $35.00 ➝ $37.00 | Buy | 00.00% | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 9/17/2026 |
CRM Salesforce | $224.52 -2.3% | 9/17/2026 | | Boost Price Target | $270.00 ➝ $300.00 | Buy | 00.00% | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 9/17/2026 |
PAYX Paychex | $101.02 +1.2% | 9/17/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Paychex (NASDAQ:PAYX) on 9/17/2026 |
LYFT Lyft | $15.76 +0.2% | 9/17/2026 | | Downgrade | $22.00 ➝ $16.00 | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Lyft (NASDAQ:LYFT) on 9/17/2026 |
DY Dycom Industries | $290.76 +6.0% | 9/17/2026 | | Reiterated Rating | $620.00 | Buy | 00.00% | View details for Guggenheim rating of Dycom Industries (NYSE:DY) on 9/17/2026 |
YSWY Yesway | $20.25 +0.9% | 9/17/2026 | | Reiterated Rating | $32.00 | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 9/17/2026 |
RDDT Reddit | $148.80 -1.1% | 9/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 9/16/2026 |
SYY Sysco | $77.42 +1.4% | 9/16/2026 | | Reiterated Rating | $90.00 | Buy | 00.00% | View details for Guggenheim rating of Sysco (NYSE:SYY) on 9/16/2026 |
TRAX First Tracks Biotherapeutics | $31.39 -4.8% | 9/16/2026 | | Initiated Coverage | $100.00 | Buy | 00.00% | View details for Guggenheim rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 9/16/2026 |
TRAX First Tracks Biotherapeutics | $31.39 -4.8% | 9/16/2026 | | Initiated Coverage | $100.00 | Buy | 00.00% | View details for Guggenheim rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 9/16/2026 |
FTH Sensei Biotherapeutics | $26.89 -0.8% | 9/16/2026 | | Initiated Coverage | $70.00 | Buy | 00.00% | View details for Guggenheim rating of Sensei Biotherapeutics (NASDAQ:FTH) on 9/16/2026 |
TRAX First Tracks Biotherapeutics | $31.39 -4.8% | 9/16/2026 | | Initiated Coverage | $100.00 | Buy | 00.00% | View details for Guggenheim rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 9/16/2026 |
ULTA Ulta Beauty | $547.29 +0.8% | 9/15/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Guggenheim rating of Ulta Beauty (NASDAQ:ULTA) on 9/15/2026 |
IONS Ionis Pharmaceuticals | $44.00 +1.1% | 9/15/2026 | | Lower Price Target | $89.00 ➝ $80.00 | Buy | 00.00% | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/15/2026 |
IVA Inventiva | $3.46 -0.6% | 9/15/2026 | | Boost Price Target | $11.00 ➝ $14.00 | Buy | 00.00% | View details for Guggenheim rating of Inventiva (NASDAQ:IVA) on 9/15/2026 |
WEN Wendy's | $6.16 +1.0% | 9/15/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Wendy’s (NASDAQ:WEN) on 9/15/2026 |
NYT New York Times | $64.12 +0.2% | 9/15/2026 | | Upgrade | $70.00 ➝ $82.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of New York Times (NYSE:NYT) on 9/15/2026 |
FTH Sensei Biotherapeutics | $26.89 -0.8% | 9/15/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Sensei Biotherapeutics (NASDAQ:FTH) on 9/15/2026 |
MOG.A Moog | $376.31 -1.2% | 9/15/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Moog (NYSE:MOG.A) on 9/15/2026 |
NBTX Nanobiotix | $25.23 +0.5% | 9/15/2026 | | Initiated Coverage | $64.00 | Buy | 00.00% | View details for Guggenheim rating of Nanobiotix (NASDAQ:NBTX) on 9/15/2026 |
TDG Transdigm Group | $1,104.11 +1.0% | 9/15/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Transdigm Group (NYSE:TDG) on 9/15/2026 |
YSS York Space Systems | $8.03 -3.4% | 9/14/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of York Space Systems (NYSE:YSS) on 9/14/2026 |
RBC RBC Bearings | $514.61 +0.4% | 9/14/2026 | | Initiated Coverage | $600.00 | Buy | 00.00% | View details for Guggenheim rating of RBC Bearings (NYSE:RBC) on 9/14/2026 |
My top 3 AI picks for the next decade (Ad) Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005.
Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade. Click here to get all three AI stock names from Alexander Green |
MRCY Mercury Systems | $82.80 -0.2% | 9/14/2026 | | Initiated Coverage | $115.00 | Buy | 00.00% | View details for Guggenheim rating of Mercury Systems (NASDAQ:MRCY) on 9/14/2026 |
VSEC VSE | $168.48 +0.2% | 9/14/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of VSE (NASDAQ:VSEC) on 9/14/2026 |
DRS Leonardo DRS | $36.78 +0.5% | 9/14/2026 | | Initiated Coverage | $51.00 | Buy | 00.00% | View details for Guggenheim rating of Leonardo DRS (NASDAQ:DRS) on 9/14/2026 |
LHX L3Harris Technologies | $237.70 +0.3% | 9/14/2026 | | Initiated Coverage | $365.00 | Buy | 00.00% | View details for Guggenheim rating of L3Harris Technologies (NYSE:LHX) on 9/14/2026 |
KRMN Karman | $33.20 +0.6% | 9/14/2026 | | Initiated Coverage | $63.00 | Buy | 00.00% | View details for Guggenheim rating of Karman (NYSE:KRMN) on 9/14/2026 |
HEI Heico | $303.33 +0.6% | 9/14/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Heico (NYSE:HEI) on 9/14/2026 |
HXL Hexcel | $86.18 +0.3% | 9/14/2026 | | Initiated Coverage | $120.00 | Buy | 00.00% | View details for Guggenheim rating of Hexcel (NYSE:HXL) on 9/14/2026 |
AIR AAR | $103.98 +1.7% | 9/14/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of AAR (NYSE:AIR) on 9/14/2026 |
WWD Woodward | $332.56 -0.1% | 9/14/2026 | | Initiated Coverage | $404.00 | Buy | 00.00% | View details for Guggenheim rating of Woodward (NASDAQ:WWD) on 9/14/2026 |
BWXT BWX Technologies | $145.83 +7.7% | 9/14/2026 | | Initiated Coverage | $192.00 | Buy | 00.00% | View details for Guggenheim rating of BWX Technologies (NYSE:BWXT) on 9/14/2026 |